Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

Recent & Breaking News (TSXV:RP)

RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco

Canada NewsWire January 7, 2015

Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness

Canada NewsWire December 22, 2014

RepliCel Life Sciences to Present at World Stem Cell Summit 2014

Marketwired December 2, 2014

RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis

Marketwired December 1, 2014

RepliCel Announces 2014 Third Quarter Financial Results

Marketwired November 26, 2014

R. Lee Buckler: How RepliCel Is Harnessing the Awesome Power of Cell Therapy

Marketwired November 10, 2014

RepliCel Submits Clinical Trial Application to Health Canada for Its Chronic Achilles Tendinosis Trial

Marketwired October 29, 2014

RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum

Marketwired October 9, 2014

RepliCel Life Sciences Adds Industry Specialist to Management Team

Marketwired October 7, 2014

RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California

Marketwired October 2, 2014

RepliCel Retains Market-Making Services

Marketwired September 12, 2014

RepliCel Garners Feature on Fox Business News and the Financial Post

Marketwired September 9, 2014

New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body

Accesswire September 9, 2014

Cutting-Edge Advancements: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body

Accesswire September 9, 2014

Cutting-Edge Advancements: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body

GlobeNewswire September 9, 2014

RepliCel to Present at Rodman & Renshaw's 16th Annual Global Investment Conference in New York

Marketwired September 4, 2014

RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium

Marketwired September 3, 2014

RepliCel Announces 2014 Second Quarter Financial Results

Marketwired August 26, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance

Marketwired July 16, 2014